Pure Global

Qualitative DNA Test Kit for Human bocavirus 1/2/3/4 and RNA Test Kit for Human rhinovirus A/B/C, Human coronavirus 229E, Human coronavirus NL63 and Human coronavirus OC43 - Vietnam Registration 2400203ĐKLH/BYT-HTTB

Access comprehensive regulatory information for Qualitative DNA Test Kit for Human bocavirus 1/2/3/4 and RNA Test Kit for Human rhinovirus A/B/C, Human coronavirus 229E, Human coronavirus NL63 and Human coronavirus OC43 in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TTBYT Loại C medical device is registered under number 2400203ĐKLH/BYT-HTTB and manufactured by Seegene, Inc.. The authorized representative in Vietnam is CÔNG TY TNHH THIẾT BỊ Y TẾ PHƯƠNG ĐÔNG.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
300,000+ Devices
2400203ĐKLH/BYT-HTTB
Registration Details
Vietnam MOH Registration: 2400203ĐKLH/BYT-HTTB
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

Qualitative DNA Test Kit for Human bocavirus 1/2/3/4 and RNA Test Kit for Human rhinovirus A/B/C, Human coronavirus 229E, Human coronavirus NL63 and Human coronavirus OC43
VN: Bộ xét nghiệm định tính ADN Human bocavirus 1/2/3/4 và ARN Human rhinovirus A/B/C, Human coronavirus 229E, Human coronavirus NL63 và Human coronavirus OC43
Risk Class TTBYT Loại C

Registration Details

2400203ĐKLH/BYT-HTTB

000.00.04.G18-211214-0026

Allplex™ Respiratory Panel 3

RP9601Y

Company Information

REPUBLIC OF

Technical Details

Qualitative in vitro testing to detect single or multiple Human bocavirus 1/2/3/4 (HBoV), Human rhinovirus A/B/C (HRV), Human coronavirus 229E (229E), Human coronavirus NL63 (NL63) and Human coronavirus OC43 (OC43) from the nasopharyngeal aspirate, nasal aspirate and bronchoalveolar lavage samples.

Dates and Status

Feb 04, 2024